13F Data
13F filer · CIK 1792424

Link Fund Solutions Ltd

LONDON, X0 · filing since Q4 2019 · last filing Jul 7, 2020
Reported value
$0
$-156.8M vs prior
Positions
1
New / sold out
1 / 2
Added / reduced
0 / 0
Turnover
0.0%
buys $0 · sells $156.8M
Top-10 weight
–

Biggest buys vs Q1 2020

ChangeSecurityShares changeChange %Est. trade value
New00––

Biggest sells vs Q1 2020

ChangeSecurityShares changeChange %Est. trade value
Sold outTheravance Biopharma, Inc.-4,836,864-100.0%$-111.3M
Sold outEvofem Biosciences, Inc.-9,138,504-100.0%$-45.5M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2019: $193.9MQ1 2020: $156.8MQ2 2020: $0
Q4 2019Q2 2020

Holdings · Q2 2020

#SecuritySharesValueWeight
1000$0–